Cargando…
Mechanism of Action and Efficacy of Immunosupressors in Lupus Nephritis
Approximately 70% of the patients with systemic lupus erythematosus will have clinical evidence of kidney damage during their evolution. Patients with impaired renal function at onset and those with recurrent flares have a poor prognosis. Understanding the mechanism of action of immunosuppressants i...
Autores principales: | Alamilla-Sanchez, Mario E, Alcala-Salgado, Miguel A, Alonso-Bello, Cesar D, Fonseca-Gonzalez, Gandhy T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675090/ https://www.ncbi.nlm.nih.gov/pubmed/34924767 http://dx.doi.org/10.2147/IJNRD.S335371 |
Ejemplares similares
-
Lupus Nephritis: An Overview of Recent Findings
por: de Zubiria Salgado, Alberto, et al.
Publicado: (2012) -
Mechanisms of tissue injury in lupus nephritis
por: Nowling, Tamara K, et al.
Publicado: (2011) -
The Network of Inflammatory Mechanisms in Lupus Nephritis
por: Nozaki, Yuji
Publicado: (2020) -
Clinical efficacy and safety of rituximab in lupus nephritis
por: Zhong, Zhiqing, et al.
Publicado: (2019) -
Podocyte Injury in Lupus Nephritis
por: Sakhi, Hamza, et al.
Publicado: (2019)